PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Master the Science of Success

Biotech in the Age of COVID: The Pain and the Gain

CFOs Outlook: Forging a Sustainable Future

Annual Feature
Emerging Pharma Leaders 2020
Pharm Exec presents the diverse stories of 11 rising biopharma managers.
... /Read more/

Advertisement
Using Big Data to Build Excellent Forecasts
Wednesday, June 24, 2020 at 11am EDT
Register now

Artificial Intelligence
AI: Kickstarting the Race Against COVID-19
Hunting for effective treatments, tools offer support in global fight.
... /Read more/

Advertisement
Now and Next: A COVID-19 Access and Patient Engagement Update
Thursday, May 28, 2020 at 11am EDT
Register now

Biopharma
Biopharma Sustainability Considered Essential
The commercial and social value of non-financial performance.
... /Read more/
Calendar
 
/ DIA 2020 Global Annual Meeting — 6/14-6/18 /
 
/ BePharma 2020 — 6/15-6/17 /
 
/ Patient Support Services Congress— 6/16-6/18 /
 


 

Coronavirus Pandemic
Vaccine Production Key to Global Pandemic Response
Biopharma companies have been working overtime to supply billions of doses of any safe and effective preventive. But the tight timeframe means they can't wait for final clinical test results to begin preparing large-scale manufacturing operations and to address critical supply chain issues.
... /Read more/
The Pharm Exec Podcast: Episode 56
Killing Cancer Through Direct Injection
Lew Bender, founder of Intensity Therapeutics and the inventor of Intensity’s DfuseRx platform technology, discusses the technology that allows the company’s therapeutic products to be injected directly into solid tumors, this innovative process successfully kills tumors and activates an immune response to shut down cancer cells throughout the body.
... /Read more/

 
update my profile / advertise with us / print & digital subscribe / visit pharmexec.com